je.st
news
Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer
2015-04-13 16:44:27| Biotech - Topix.net
Blend Therapeutics, Inc. , a biopharmaceutical company discovering and developing two distinct classes of targeted anti-cancer medicines to advance the treatment of patients with solid tumor cancers, announced today the appointment of Drew Fromkin as President and Chief Executive Officer and a member of the company's Board of Directors. Mr. Fromkin previously served as President and Chief Executive Officer of Clinical Data, Inc., until its acquisition by Forest Laboratories.
Tags: executive
president
chief
officer
Category:Biotechnology and Pharmaceuticals